Cargando…
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead.
Associations between the presence of a constitutional variant of delta-aminolevulinic acid dehydratase (ALAD-2) and lead concentrations in blood and bone, as well as between this allele and indices of kidney function, were investigated among 691 members of a construction trade union. The average blo...
Autores principales: | Smith, C M, Wang, X, Hu, H, Kelsey, K T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1519085/ https://www.ncbi.nlm.nih.gov/pubmed/7768225 |
Ejemplares similares
-
A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study.
por: Wu, Ming-Tsang, et al.
Publicado: (2003) -
Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden.
por: Wetmur, J G
Publicado: (1994) -
The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study.
por: Hu, H, et al.
Publicado: (2001) -
Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes.
por: Schwartz, B S, et al.
Publicado: (2000) -
Association between Blood Lead Levels and Delta-Aminolevulinic Acid Dehydratase in Pregnant Women
por: La-Llave-León, Osmel, et al.
Publicado: (2017)